Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-23
DOI
10.3389/fpsyt.2021.648273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence Synthesis of Digital Interventions to Mitigate the Negative Impact of the COVID-19 Pandemic on Public Mental Health: Rapid Meta-review
- (2021) Christian Rauschenberg et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Clinicians' Perceptions of Rapid Scale-up of Telehealth Services in Outpatient Mental Health Treatment
- (2021) Dawn E. Sugarman et al. Telemedicine and e-Health
- Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects
- (2020) Fabrizio Schifano Brain Sciences
- Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario
- (2020) Davide Arillotta et al. Frontiers in Neuroscience
- COVID-19: The Hidden Impact on Mental Health and Drug Addiction
- (2020) Stefania Chiappini et al. Frontiers in Psychiatry
- Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
- (2020) Michael Specka et al. Frontiers in Psychiatry
- High lifetime, but low current, prevalence of new psychotropic substances (NPS) use in German drug detoxification treatment young inpatients
- (2020) Norbert Scherbaum et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabis and COVID-19: Reasons for Concern
- (2020) Margriet W. van Laar et al. Frontiers in Psychiatry
- Monitoring drug consumption in Innsbruck during coronavirus disease 2019 (COVID-19) lockdown by wastewater analysis
- (2020) Vera Reinstadler et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Pregabalin: A range of misuse-related unanswered questions
- (2019) Fabrizio Schifano et al. CNS Neuroscience & Therapeutics
- Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
- (2018) Patil Armenian et al. NEUROPHARMACOLOGY
- How addictive are gabapentin and pregabalin? A systematic review
- (2017) U. Bonnet et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- An insight into the deep web; why it matters for addiction psychiatry?
- (2017) Laura Orsolini et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- New Psychoactive Substances (NPS) – a Challenge for the Addiction Treatment Services
- (2017) Norbert Scherbaum et al. PHARMACOPSYCHIATRY
- A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database
- (2016) Stefania Chiappini et al. CNS DRUGS
- Factors influencing the course of opiate addiction
- (2008) N. Scherbaum et al. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started